Cargando…
Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?
Gabapentin is widely used in the United States for a number of off-label indications, often as an alternative to opioid therapy. Increasing evidence has emerged suggesting that gabapentin may not be as benign as once thought and may be associated with substance abuse in concert with opioids. With co...
Autores principales: | Peckham, Alyssa M, Evoy, Kirk E, Ochs, Leslie, Covvey, Jordan R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153543/ https://www.ncbi.nlm.nih.gov/pubmed/30262984 http://dx.doi.org/10.1177/1178221818801311 |
Ejemplares similares
-
Receipt of Substance Use Counseling Among Ambulatory Patients
Prescribed Opioids in the United States
por: Evoy, Kirk E, et al.
Publicado: (2020) -
Letter to the Editor: Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
por: Peckham, Alyssa M., et al.
Publicado: (2021) -
Examination of the Evidence for Off-Label Use of Gabapentin
por: Mack, Alicia
Publicado: (2003) -
Gabapentin May Be Appropriate for Off-Label Uses
por: Davis, Shawn
Publicado: (2003) -
Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance
por: Peckham, Alyssa M, et al.
Publicado: (2018)